Pharmazie in Unserer Zeit最新文献

筛选
英文 中文
[Similar but not identical biosimilars: the vision of innovators]. [相似但不完全相同的生物仿制药:创新者的愿景]。
Pharmazie in Unserer Zeit Pub Date : 2012-11-01 DOI: 10.1002/pauz.201200494
Sabine Sydow, Karl-Heinz Grajer
{"title":"[Similar but not identical biosimilars: the vision of innovators].","authors":"Sabine Sydow, Karl-Heinz Grajer","doi":"10.1002/pauz.201200494","DOIUrl":"https://doi.org/10.1002/pauz.201200494","url":null,"abstract":"","PeriodicalId":19878,"journal":{"name":"Pharmazie in Unserer Zeit","volume":"41 6","pages":"474-80"},"PeriodicalIF":0.0,"publicationDate":"2012-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/pauz.201200494","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"31198235","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Homöopathie für die junge Familie. Von Brigitte M. Gensthaler 他们年轻的家庭可以吃顺势疗法来自布里吉tte m
Pharmazie in Unserer Zeit Pub Date : 2012-11-01 DOI: 10.1002/PAUZ.201290113
Christian Redmann
{"title":"Homöopathie für die junge Familie. Von Brigitte M. Gensthaler","authors":"Christian Redmann","doi":"10.1002/PAUZ.201290113","DOIUrl":"https://doi.org/10.1002/PAUZ.201290113","url":null,"abstract":"","PeriodicalId":19878,"journal":{"name":"Pharmazie in Unserer Zeit","volume":"75 1","pages":"504-505"},"PeriodicalIF":0.0,"publicationDate":"2012-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85559388","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[What is exactly alike? High-performance analytics for development of biosimilars]. 什么是完全一样的?生物仿制药开发的高性能分析]。
Pharmazie in Unserer Zeit Pub Date : 2012-11-01 DOI: 10.1002/pauz.201200493
Martin Blüggel
{"title":"[What is exactly alike? High-performance analytics for development of biosimilars].","authors":"Martin Blüggel","doi":"10.1002/pauz.201200493","DOIUrl":"https://doi.org/10.1002/pauz.201200493","url":null,"abstract":"","PeriodicalId":19878,"journal":{"name":"Pharmazie in Unserer Zeit","volume":"41 6","pages":"468-73"},"PeriodicalIF":0.0,"publicationDate":"2012-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/pauz.201200493","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"31198234","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Eine kurze Geschichte der Genetik. Von Rolf Knippers 遗传学的简史Rolf kni别扭
Pharmazie in Unserer Zeit Pub Date : 2012-11-01 DOI: 10.1002/PAUZ.201290108
Thomas Winckler
{"title":"Eine kurze Geschichte der Genetik. Von Rolf Knippers","authors":"Thomas Winckler","doi":"10.1002/PAUZ.201290108","DOIUrl":"https://doi.org/10.1002/PAUZ.201290108","url":null,"abstract":"","PeriodicalId":19878,"journal":{"name":"Pharmazie in Unserer Zeit","volume":"72 1","pages":"503-503"},"PeriodicalIF":0.0,"publicationDate":"2012-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84104719","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Cost-effectiveness advantage? Pharmacoeconomic aspects of biosimilars]. (成本效益优势?生物仿制药的药物经济学方面]。
Pharmazie in Unserer Zeit Pub Date : 2012-11-01 DOI: 10.1002/pauz.201200496
Evelyn Walter
{"title":"[Cost-effectiveness advantage? Pharmacoeconomic aspects of biosimilars].","authors":"Evelyn Walter","doi":"10.1002/pauz.201200496","DOIUrl":"https://doi.org/10.1002/pauz.201200496","url":null,"abstract":"2010 wurden in Deutschland 26 Arzneimittel mit neuen Wirkstoffen (international auch als NME – New Molecular Entity – bezeichnet) im Markt eingefuhrt. Bei den Ausgaben fur Arzneimittel liegt Deutschland mit einem Anteil von 15,1 % an den gesamten Gesundheitsausgaben (rund 280 Mrd. Euro) nach wie vor deutlich unter dem Niveau der meisten europaischen Lander und Japans. Die Ausgaben der GKV fur Arzneimittel betragen 32,0 Mrd. Euro oder 18 %. Von den Gesamtausgaben der GKV entfallen nur 4 % (6,7 Mrd. Euro) auf patentgeschutzte Arzneimittel.","PeriodicalId":19878,"journal":{"name":"Pharmazie in Unserer Zeit","volume":"41 6","pages":"485-91"},"PeriodicalIF":0.0,"publicationDate":"2012-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/pauz.201200496","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"31198237","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Comparison of generics and original biopharmaceutical drugs. The clinical development of biosimilars]. [仿制药与原研生物药的比较。][生物仿制药的临床发展]。
Pharmazie in Unserer Zeit Pub Date : 2012-11-01 DOI: 10.1002/pauz.201200492
Carsten Brockmeyer
{"title":"[Comparison of generics and original biopharmaceutical drugs. The clinical development of biosimilars].","authors":"Carsten Brockmeyer","doi":"10.1002/pauz.201200492","DOIUrl":"https://doi.org/10.1002/pauz.201200492","url":null,"abstract":"Biosimilare Arzneimittel (Biosimilars) sind Nachfolgeprodukte biomedizinischer Arzneimittel, die ihren Patentschutz verloren haben. Im Gegensatz zu “klassischen” Generika werden fur Biosimilars in jedem Fall klinische Studien gefordert.","PeriodicalId":19878,"journal":{"name":"Pharmazie in Unserer Zeit","volume":"41 6","pages":"461-7"},"PeriodicalIF":0.0,"publicationDate":"2012-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/pauz.201200492","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"31198233","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Editorial: Pharmazie in unserer Zeit 6/2012]. [专栏作家:在unserer Zeit 6/2012中的pharm感谢]。
Pharmazie in Unserer Zeit Pub Date : 2012-11-01 DOI: 10.1002/pauz.201290096
Theo Dingermann
{"title":"[Editorial: Pharmazie in unserer Zeit 6/2012].","authors":"Theo Dingermann","doi":"10.1002/pauz.201290096","DOIUrl":"https://doi.org/10.1002/pauz.201290096","url":null,"abstract":"","PeriodicalId":19878,"journal":{"name":"Pharmazie in Unserer Zeit","volume":"41 6","pages":"439"},"PeriodicalIF":0.0,"publicationDate":"2012-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/pauz.201290096","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"31023630","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[When two do the same, it is not the same. Requirements for development and quality of biosimilars]. 两个人做同样的事,结果就不一样了。生物仿制药的开发和质量要求[j]。
Pharmazie in Unserer Zeit Pub Date : 2012-11-01 DOI: 10.1002/pauz.201200491
Isam Rais
{"title":"[When two do the same, it is not the same. Requirements for development and quality of biosimilars].","authors":"Isam Rais","doi":"10.1002/pauz.201200491","DOIUrl":"https://doi.org/10.1002/pauz.201200491","url":null,"abstract":"","PeriodicalId":19878,"journal":{"name":"Pharmazie in Unserer Zeit","volume":"41 6","pages":"453-60"},"PeriodicalIF":0.0,"publicationDate":"2012-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/pauz.201200491","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"31198232","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
DPhG Aktuell: Editorial
Pharmazie in Unserer Zeit Pub Date : 2012-11-01 DOI: 10.1002/PAUZ.201290104
T. Dingermann, M. Schubert-Zsilavecz, D. Steinhilber, Klaus Mickus, Carol Bacchus
{"title":"DPhG Aktuell: Editorial","authors":"T. Dingermann, M. Schubert-Zsilavecz, D. Steinhilber, Klaus Mickus, Carol Bacchus","doi":"10.1002/PAUZ.201290104","DOIUrl":"https://doi.org/10.1002/PAUZ.201290104","url":null,"abstract":"","PeriodicalId":19878,"journal":{"name":"Pharmazie in Unserer Zeit","volume":"42 1","pages":"494-494"},"PeriodicalIF":0.0,"publicationDate":"2012-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82333608","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[White, brown or beige rather?]. [白色、棕色还是米色?]
Pharmazie in Unserer Zeit Pub Date : 2012-11-01 DOI: 10.1002/pauz.201290099
Ilse Zündorf, Theo Dingermann
{"title":"[White, brown or beige rather?].","authors":"Ilse Zündorf, Theo Dingermann","doi":"10.1002/pauz.201290099","DOIUrl":"https://doi.org/10.1002/pauz.201290099","url":null,"abstract":"","PeriodicalId":19878,"journal":{"name":"Pharmazie in Unserer Zeit","volume":"41 6","pages":"443-4"},"PeriodicalIF":0.0,"publicationDate":"2012-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/pauz.201290099","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"31198230","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信